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A Point Mutation in the Constant Region
of Ig Lambda1 Prevents Normal B Cell Development
due to Defective BCR Signaling
selective 50-fold decrease in 1 (Geckeler et al., 1978;
Ju et al., 1986), which persists in mice deficient in  (Kim
et al., 1994). Genetic studies have demonstrated that
the SJL 1 defect is linked to the  locus within 2.3
cM (Epstein et al., 1983, 1984). To examine whether the
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defect resides within this locus, we previously charac-
terized and sequenced the functional elements in the
1 locus, including the promoter, enhancers, recombi-Summary
nation signal sequences, RNA splice sites, and exons
(Arp et al., 1982; Kim et al., 1994). The only mutationSurface expression of B cell antigen receptors (BCRs)
containing Ig and Ig/Ig generates signals required to found in SJL was the substitution of a valine codon
(GTT) for a glycine codon (GGT) at position 154 in thetransit discrete developmental checkpoints. The mecha-
nism by which BCR components collaborate to initiate C1 exon. We postulated that the valine mutation might
be involved in the 1 deficiency of SJL mice.signals is still unclear. The expression of Ig1 in SJL
mice is 50-fold lower than in other strains. Here, we To determine whether the valine mutation or perhaps
an as yet undetected regulatory element was responsi-demonstrate by gene targeting that a point mutation,
which changes a glycine to a valine in the 1 constant ble for the SJL defect, we generated mice targeted with
a valine codon substitution at position 154 in the 1region, is responsible for this defect. In vitro experi-
ments show that Ig receptors bearing this mutation, exon. The neomycin phosphotransferase gene under
the control of the housekeeping promoter for phospho-while expressed normally, are deficient in signaling.
These findings reveal a direct involvement of the Ig light glycerine kinase (PGK-neo), inserted upstream of the
J1 element, serves as the selection marker for genechain (IgL) in B cell signaling and development beyond
the requirement of light chains for BCR assembly. targeting. In previous targeting experiments, PGK-neo
inserted into the  or heavy chain loci severely inhibited
V(D)J recombination (Sleckman et al., 1996). To deter-Introduction
mine the effect of PGK-neo in our particular gene tar-
geting experiment, we first generated a control mouseDeveloping B cells in the bone marrow transit through
developmental stages defined by the sequential re- targeted with the PGK-neo cassette and a serine codon
(AGC) at position 154 in the C1 exon. Serine was chosenarrangement of Ig genes and expression of specific cell
surface markers. After initial commitment to the B cell because it is found in certain human and chimpanzee
 light chains at this amino acid position, although gly-lineage, cells pass through the pro-B cell stage to be-
come large pre-B cells, in which VHDHJH is rearranged cine is highly conserved in other vertebrate species. We
reasoned that a serine at position 154 would functionand expressed on the cell surface with surrogate light
chains (sL), VpreB, and 5. The membrane-expressed as well as a glycine. The surprising phenotype of the
mice (named S-n, for serine-neo) targeted with the serineIgH/sL complex associates with Ig/Ig heterodimers
to form the pre-BCR complex, which initiates signals codon mutation and PGK-neo has been described (Sun
and Storb, 2001). In brief, while the serine mutation ap-required for transition to the small pre-B cell stage (Kita-
mura et al., 1992, 1991). In these cells, Ig light chains ( pears to have no effect on B cell development, the PGK-
neo cassette, when residing upstream of J1, dramati-and ) start to rearrange, and functional light chains
replace surrogate light chains to form IgM on the cell cally enhances rather than inhibits VJ1 rearrangement.
This upregulation of VJ1 rearrangement is apparentlysurface of immature B cells. Following egress from the
bone marrow, B lymphocytes mature in the periphery due to an increased level of J1 germline transcription
caused by the PGK-neo insertion. For the purpose ofand acquire IgD surface expression. Genetic studies
have demonstrated that each of the BCR constituents targeting the valine mutation described here, the serine
mutation serves as an important control.is required for B cell development and maturation. How-
ever, it is unclear, in the absence of a demonstrable
selecting ligand, how surface expression of the receptor Results
complex initiates requisite signals (Pillai, 1999). In addi-
tion, no report has suggested any role played by the Generation of the V-n Gene-Targeted Mice
light chain itself beyond a requirement for receptor as- Gene targeting was used to create the valine knockin
sembly in B cell development. The knockout of an Ig mouse line (named V-n, for valine-neo) in which a point
light chain, such as , simply eliminates the presence mutation was introduced that changed the glycine co-
of  B cells altogether (Chen et al., 1993). don (GGT) to a valine codon (GTT) at position 154 in
In most mouse strains, 95% of the total IgL in the the C1 exon (Figures 1A and 1B). PGK-neo, inserted
serum is  and only 5% is . The majority (80%) of the upstream of the J1 element, served as the selection
 Ig is of the 1 subtype, while the rest is 2 or 3. In marker for gene targeting. To make sure that the PGK-
contrast, the SJL and its related mouse strains have a neo cassette has the same effect in the V-n mice as in
the S-n mice, the PGK-neo cassette was placed in the
V-n mice at exactly the same position base by base as3 Correspondence: stor@midway.uchicago.edu
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Figure 1. Targeting of V-n into the Ig1 Locus
in ES Cells and Mice
(A) A general map of the Ig locus is shown
at the top. In the targeting vector, a PGK-neo
cassette flanked by two loxP sites (shown as
black triangles) was inserted 100 bp up-
stream of the J1 RSS region, exactly at the
same position as in S-n-targeted mice (Sun
and Storb, 2001). A point mutation (*) was
introduced into the C1 exon at amino acid
position 154, disrupting a KpnI/Asp718 re-
striction site. The probes used in this study
are indicated by black bars. The restriction
sites are shown as O (XhoI), X (XbaI), H
(HindIII), K (KpnI/Asp718), and E (EcoRI). E2-
4 and E3-1 are the  enhancers.
(B) The sequences in the C1 region where
the point mutation was introduced. A glycine
codon (GGT) was replaced by a valine codon
(GTT) at position 154.
(C) Southern blot with the 3C1 probe (Figure 1A)
identified V-n-targeted mice by HindIII-Asp718
digestion of kidney DNA from /, 1 wild-type
(G/G), heterozygous-targeted (G/V-n), or homo-
zygous-targeted (V-n/V-n) mice. The targeted
allele (V-n) gives an 8 kb band, whereas the
wild-type allele (G) gives a 4.7 kb band.
in the S-n mice. The valine codon point mutation disrupts PCR amplification is unlikely to favor one or the other. PCR
a KpnI/Asp718 restriction site as does the serine muta- products were then digested with Asp718 and analyzed by
tion. Mutant ES clones were injected into C57BL/6 blas- Southern blot to distinguish the two rearranged alleles
tocysts to create the V-n-targeted mice (Figure 1C). For (Figure 2A). As is seen in the spleen of the G/S-n mouse,
some experiments, germline transmitting mice were also in the G/V-n mouse the intensity of the rearranged gene
bred onto an Ig/ background. targeted band (V-n, Asp718 resistant) is also greater
than that of the rearranged wild-type band (G, for gly-
cine, Asp718 susceptible, Figure 2B). The increased in-PGK-neo Promotes VJ Recombination in V-n Mice
tensity in the rearranged V-n allele could reflect eitherTo examine rearrangement in the V-n-targeted allele,
more efficient recombination of the targeted allele duethe 1 region was amplified by PCR from the genomic
to the PGK-neo insertion as in the S-n allele (Sun andDNA of spleen cells isolated from Ig wild-type, 1 het-
Storb, 2001) or more favorable valine 1 B cell selectionerozygous mice (/, 1(G/V-n)). Since in heterozygous
during B cell development. To distinguish between thesemice the sequences resulting from rearrangements of
the two alleles differ by only one base pair (GGT to GTT), two possibilities, we sequenced the rearranged products
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Figure 2. Valine Knockin Mice Show a High
VJ Rearrangement in the Targeted Allele
(A) Location of primers used for PCR are
shown by small arrows. The gray box indi-
cates the probe (Figure 1A, probe J1XbaI-
C1KpnI) used in the Southern blot in Figure
2B. The PCR product of the rearranged wild-
type allele contains a KpnI/Asp718 site, while
that of the targeted allele does not.
(B) Splenic DNA samples from the indicated
mice were PCR amplified. The PCR products
were further digested by Asp718 (shown in
the “cut” lanes). Samples from the wild-type
(G/G) and homozygous S-n (S-n/S-n) mice
were included as positive and negative diges-
tion controls.
from the spleen. Since every valine 1 B cell must carry -2, -3) and are represented in the periphery. Therefore,
the finding of 25% productive rearrangements of thea productively rearranged 1 allele to produce the 1 pro-
tein, a favorable cell selection would lead to the increase S-n allele is within the expected range. Strikingly, the
frequency of productively rearranged V-n alleles in twoof the productively rearranged allele in the spleen. How-
ever, we found that most of the rearrangements from the G/V-n mouse samples was reduced about 10-fold (2.7%,
0 out of 20 and 1 out of 17, Table 1). Most recombinationsV-n allele were nonproductive (see below, Table 1). This
suggests that, in contrast to S-n mice, the valine 1 B cells were unique, suggesting that our results were not due
to PCR artifact. In fact, if only the nonidentical re-are selected against rather than favorably (also see below).
Nevertheless, as in the S-n mice (Sun and Storb, 2001), arrangements are considered, 31% of the S-n alleles
are productive (4 out of 13), but only 4.7% of the V-nthe PGK-neo insertion also enhances VJ1 rearrangement
in the V-n mice. alleles are (1 in 21). Because the valine-targeted allele
is fully competent to recombine (Figure 2B), the low
percentage of productive 1 rearrangements in the tar-Development of B Cells with Productively Rearranged
geted allele must be due to selection against B cellsValine 1 Loci Is Inhibited
producing the valine 1 protein.Although in /, 1(G/V-n) heterozygous mice  B cells
constitute the majority of total B cells, the develop-
mental status of valine 1 B cells can be assessed by Low 1 B Cell Numbers in Bone Marrow and Spleen
of V-n/V-n Miceexamining whether peripheral 1 gene rearrangements
are productive or nonproductive. The VJ1-rearranged To restrict the B cell population to -expressing cells,
V-n mice were bred onto a  knockout background.products from splenic DNA samples of G/V-n mice were
PCR amplified. PCR products not cut by Asp718, repre- FACS analysis was performed on the bone marrow and
spleen cells from these mice (Figures 3 and 4). In thesenting the V-n allele, were cloned and sequenced.
VJ1-rearranged products from a G/S-n mouse served absence of , the 1 subpopulation in V-n/V-n mice
constitutes 23.3% (3.74% out of 16.04%) and 12.6%as a control. In two independent experiments, 25% of
S-n clones were productively rearranged (2 out of 9 and (4.98% out of 39.48%) of total B cells in bone marrow
and spleen, respectively. These numbers are strikingly3 out of 11, Table 1). In the bone marrow, there is a
1/3 chance that 1 rearrangement will be productive. lower than those from 1 wild-type mice (G/G, 56% and
58%) in bone marrow and spleen, respectively (FiguresNonproductive rearrangements are rescued by subse-
quent rearrangement of other light chain loci (, gly-1, 3A and 3B). Very similar results were also found in the
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Table 1. Sequence Analysis of VJ1 Rearranged Clones from the Targeted Allele in the Spleens of /, G/S-n, or G/V-n 1
Heterozygous Mouse
Experiment 1 Experiment 2
Germline Sequence Frame Germline Sequence Frame
V1-AAC CAT TTC C TGG GTG TTC GGT-J1 V1-AAC CAT TTC C TGG GTG TTC GGT-J1
V-n V-n
1 AAC CAT T-- - --- GTG TTC GGT  1 AAC CAT TTC - --G GTG TTC CCT 
2 AAC CAT --- C TGG GTG TTC GGT  2 AAC CAT --- - -GG GTG TTC GGT 
3 AAC CAT --- - -GG GTG TTC GGT  3 AAC CAT TTC - -GG GTG TTC GGT 
4 AAC CAT TT- - -GG GTG TTC GGT  4 AAC C-- --- - TGG GTG TTC GGT 
5 AAC CAT TT- - -GG GTG TTC GGT  5 AAC CAT TT- - -GG GTG TTC GGT 
6 AAC CAT T-- - --- --- --C GGT  6 AAC C-- --- C TGG GTG TTC GGT 
7 AAC CAT TT- - TGG GTG TTC GGT  7 AAC C-- --- - TGG GTG TTC GGT 
8 AAC CAT --- - -GG GTG TTC GGT  8 AAC CAT TT- - -GG GTG TTC GGT 
9 AAC CAT --- - -GG GTG TTC GGT  9 AAC CAT TTC T - --- GTG TTC GGT 
10 AAC CAT TT- - -GG GTG TTC GGT  10 AAC CA- --- G C TGG GTG TTC GGT 
11 AAC C-- --- - TGG GTG TTC GGT  11 AAC CAT TT-- - -GG GTG TTC GGT 
12 AAC C-- --- C TGG GTG TTC GGT  12 AAC CAT TT- - -GG GTG TTC GGT 
13 AAC CAT TT- - -GG GTG TTC GGT  13 AAC CAT TT- - TGG GTG TTC GGT 
14 AAC CAT TTC - -GG GTG TTC GGT  14 AAC CAT TT- - -GG GTG TTC GGT 
15 AAC CAT TT- - -GG GTG TTC GGT  15 AAC CAT T-- A - --- GTG TTC GGT 
16 AAC CAT TT- - -GG GTG TTC GGT  16 AAC CAT TT- - --G GTG TTC GGT 
17 AAC CAT TT- - -GG GTG TTC GGT  17 AAC C-- --- C TGG GTG TTC GGT 
18 AAC CAT TT- - -GG GTG TTC GGT 
19 AAC CAT TT- - -GG GTG TTC GGT 
20 AAC CAT TT- - -GG GTG TTC GGT 
S-n S-n
1 AAC CAT T-- - TGG GTG TTC GGT  1 AA- --- --- - -GG GTG TTC GGT 
2 AAC CAT T-- - TGG GTG TTC GGT  2 AAC CA- --- C TGG GTG TTC GGT 
3 AAC CAT T-- - -GG GTG TTC GGT  3 AAC CA- --- C TGG GTG TTC GGT 
4 AAC CAT TT- - --- GTG TTC GGT  4 AAC CAT TT- - -GG GTG TTC GGT 
5 AAC CAT TTC - -GG GTG TTC GGT  5 AAC CAT TT- - -GG GTG TTC GGT 
6 AAC CAT --- AG C TGG GTG TTC GGT  6 AAC CAT TTC - -GG GTG TTC GGT 
7 AAC C-- --- C TGG GTG TTC GGT  7 AAC CAT T-- - -GG GTG TTC GGT 
8 AAC CAT T-- - TGG GTG TTC GGT  8 AAC CAT --- C TGG GTG TTC GGT 
9 AAC CAT --- - --G GTG TTC GGT  9 AAC CAT TT- - -GG GTG TTC GGT 
10 AAC CAT TT- - -GG GTG TTC GGT 
11 AAC CAT TT-- - -GG GTG TTC GGT 
Two independent PCR experiments were performed for each genotype, and the results are listed in separate sections. The coding end
sequences at V1 and J1 are shown on top. Each line represents an individual clone. Nucleotide deletions are indicated by dashes. N
nucleotides are shown as underlined italic letters in the middle column, whereas P nucleotides are shown as italic letters. The in-frame clones
are indicated as “” and out-of-frame clones are indicated as “” in the “frame” columns. Two separate G/V-n mouse samples and one
G/S-n sample were used.
spleen of wild-type mice by Boudinot et al. (1995). Thus, overlap each other (Figure 3D). Therefore, the pro- and
pre-B cell development is essentially normal in V-n/V-nin V-n/V-n mice, the proportion of 1 B cells is severely
decreased. In addition, while the total number of bone mice. This is not surprising since B cells do not rearrange
their Ig light chain alleles until the late pre-B cell stagemarrow 1 B cells in V-n/V-n mice only decreases 4.5-fold
when compared with the wild-type mice (0.22 versus (Engel et al., 1999), and even in the presence of the
PGK-neo insertion, the Ig1 rearrangement does not1.0 	 106 cells, Figure 3A), the number of splenic 1
B cells decreases 10.5-fold (1.1 versus 11.6 	 106 cells, seem to advance into an earlier stage (Sun and Storb,
2001). In other words, the Ig1 protein only starts to beFigure 3B). These observations suggest that the valine
at position 154 inhibits the development of 1 B cells translated and expressed when B cells develop from
late pre-B to immature stages.both in the bone marrow and in the periphery.
To dissect other developmental stages of 1 B cells,
bone marrow and splenic cells were further stained (Fig-1 B Cell Development Is Defective in the Immature/
Transitional Stage and Continues into the Mature ures 4A–4D). In the bone marrow, immature B cells
(B220loIgM) can be distinguished from mature recircu-Stage in V-n/V-n Mice
The pro- and pre-B cell stages were analyzed in both lating B cells (B220hiIgM) by the intensity of the B220
staining (Figure 4A). Compared to the wild-type mice,mouse types (Figures 3C and 3D). The pro- and pre-
B cells were distinguished by either the CD43 marker the number of immature 1 B cells in V-n/V-n mice de-
creases 2- to 3-fold (0.13 versus 0.29 	 106), but theor cell size (Hardy et al., 1991). The pro-B cells (IgM,
B220, CD43) constitute 11.03% and 11.47%, while number of recirculating mature 1 B cells in the bone
marrow decreases 7-fold (10 versus 70 	 103, Figurethe pre-B cells (IgM, B220, CD43) constitute 34.90%
and 32.00% in wild-type (G/G) and V-n/V-n mice, respec- 4A). A similar situation is seen when IgD is used as the
cell surface marker. The immature 1 B cells (IgMIgD)tively (Figure 3C). Using cell size as a marker, the histo-
grams of IgM B220 cells from these two mice virtually are reduced 2- to 3-fold in bone marrow of V-n/V-n mice
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compared with wild-type mice (0.13 versus 0.34 	 106,
Figure 4B). However, the mature recirculating 1 B cells
are reduced almost 20-fold (5 versus 95 	 103, Figure
4B). The difference between the numbers of mature re-
circulating 1 B cells in bone marrow in Figure 4A and
4B is most likely caused by variations due to very low
cell numbers in the V-n/V-n mice (5,000 to 10,000 cells
in a whole bone marrow).
In the spleen of V-n/V-n mice, the transitional 1 B cell
population (IgMhi, IgDlo) constitutes a higher proportion
of the total 1 B cells (43.13%) than in G/G mice (33.2%)
(Figure 4C). Concomitantly, the proportion of T2 (IgMhi,
IgDhi) and mature 1 B cells (IgMlo, IgDhi) is reduced in
the V-n/V-n mice (from 19.8% [WT] to 9.39% and from
40.33% [WT] to 29.58%, respectively, Figure 4C). The
IgMhi IgDlo cell population contains both the transitional
type 1 (T1) and marginal zone populations, which can
be distinguished by anti-CD21 staining (Loder et al.,
1999). The marginal zone B cells are represented by
CD21hi, while the rest of the cells represent T1 B cells.
As shown in Figure 4D, the 1 T1 B cells (IgMhi IgDlo
CD21lo) in V-n/V-n mice decrease around 3-fold (0.16
versus 0.52 	 106). A similar degree of decrease was
also observed in the marginal zone 1 B cells (IgMhi IgDlo
CD21hi, 0.97 versus 3.4 	 106). The numbers of T2 and
mature 1 B cells, on the other hand, decrease 10- and
6-fold, respectively (0.24 versus 2.3 	 106 [T2]; 0.77
versus 4.8 	 106 [mature], Figure 4C). These results
demonstrate that both the generation of immature 1
B cells in the bone marrow and their continued matura-
tion to mature B cells in the spleen are defective in
V-n/V-n mice (see Discussion).
Defective Calcium Responses in Response
to Crosslinking Mutant 1
Valine Ig Receptors
Our findings demonstrate that the defect in B cell develop-
ment observed in SJL mice is due to a single glycine to
valine mutation in the constant region of 1. Because of
the severity of the valine 1 B cell defect in mice, we were
unable to purify enough cells ex vivo to do any functional
analysis (data not shown). To better understand the role
this mutant 1 light chain plays in B cell antigen receptor
function, we transfected the B lymphoma cell line, K46,
with plasmids encoding the Ig
 heavy chain (pSV
m5),
and either Ig1 wild-type (pSV1-neo) or the Ig1 valine
Figure 3. Valine Knockin Mice Show Low 1 B Cell Populations in (pSV1-neoval) light chain (see Experimental Procedures).
Their Bone Marrow and Spleen, but the B Cell Progenitor Population
The K46 cell line produces endogenous Ig2a/ and hasIs Normal
been used by others for B cell signaling experiments with(A) Bone marrow and (B) spleen cells from /, wild-type (G/G),
transfected BCR or other receptors (Flaswinkel and Reth,and V-n/V-n mice were double-stained with FITC-conjugated anti-
1994; Pleiman et al., 1994). Cell clones expressing either23 antibody and biotin-coupled anti-1 antibody (revealed by
PE-coupled streptavidin) and analyzed by flow cytometry. Cells wild-type (G) or mutant (V) Ig1 receptors were identified
shown are total lymphoid cells, gated by forward and side scatter. by flow cytometry.
(C and D) Bone marrow cells from /, wild-type (G/G), and V-n/ We examined whether the 1-containing BCR com-
V-n mice were stained with anti-IgM, anti-CD43, and anti-B220 anti-
plexes on each cell clone were competent to increasebodies. (C) Cells shown were first gated as lymphoid and IgM nega-
intracellular calcium following receptor ligation. Threetive. Pro-B cells are defined as IgM, B220, and CD43, while pre-
monoclonal anti- light chain antibodies were found toB cells are defined as IgM, B220, and CD43. (D) Cells shown in
the histogram were first gated as IgM and B220; cell size was be able to induce rapid and sustained intracellular cal-
used to define the cell stages: pro-B cells (IgM, B220, large) cium responses in B cells, namely R11-153 (Phar-
versus pre-B cells (IgM, B220, small). The black and gray lines mingen), 9A8 (Sigma), and L22.18.2 (Weiss et al., 1983).
stand for wild-type (G/G) and V-n/V-n mouse data, respectively. The
Strikingly, in cells expressing valine 1 receptors, intra-percentages indicate the particular cell population among all the
cellular calcium responses were greatly diminished (Fig-gated cells. The numbers in parentheses are the absolute cell num-
ures 5A–5C). Similar results were observed using allbers (	106) of the particular cell populations recovered in a mouse.
Data shown are representative of four or more for each genotype. three antibodies and with two independent clones of
Immunity
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Figure 4. Valine Knockin Mice Show De-
creased Numbers of Immature/Transitional,
Marginal Zone, and Mature 1 B Cells
(A) Bone marrow cells from /, G/G, and
V-n/V-n mice were stained with anti-1
(L22.18.2), anti-IgM, and anti-B220. The cells
shown (1 cells) were initially gated on as
lymphoid and 1 cells. The immature B cells
and recirculating naive 1 B cells are boxed to
denote IgM, B220lo, and B220hi, respectively.
(B) Same as (A), except using anti-IgM and
anti-IgD to distinguish immature (IgM, IgD)
and recirculating naive (IgM, IgD) 1
B cells.
(C and D) Spleen cells were stained with anti-
1 (L22.18.2), anti-IgM, anti-IgD, and anti-
CD21 antibodies. (C) The cells shown (1
cells) were initially gated as lymphoid and 1
staining. The IgMhi IgDlo, T2 (IgMhi, IgDhi), and
mature (IgMlo, IgDhi) cells were gated based
on their surface expression of IgM and IgD.
(D) The IgMhi IgDlo 1 B cell population was
further dissected into T1 (CD21lo) and mar-
ginal zone B cells (CD21hi) based on their sur-
face expression of CD21. A total of 50,000
events were collected for each analysis in this
figure. The percentages indicate the particu-
lar cell population among all the gated cells.
The numbers in parentheses stand for the
absolute cell numbers (	106) of particular cell
populations recovered in a mouse, except the
ones marked “E3,” which stands for 103 cells.
Data shown are representative of four or more
mice for each genotype.
each transfectant. Three of the four clones (G33, V1, other (Figure 5E). The concentrations of the antibody
that gave half of the maximal staining intensity (MFI50)and V7) showed similar expression levels of Ig1 on the
surface (Figure 5D). The other clone (G20) appeared to for both cell types are the same (0.07
g/100
l). Further-
more, the concentrations of pure 1 protein able to com-have a 2-fold higher Ig1 expression level. Nevertheless,
both of the wild-type (G) clones had similar calcium pete out half of the antibody staining intensity are also
the same (0.15 
g/100 
l, Figure 5F). Thus, the differentresponses. Apparently, the signaling capability of each
clone was not critically dependent upon surface recep- calcium responses are unlikely due to different binding
affinities for these two Ig receptors. Rather, the datator density.
The three anti- antibodies used in these experiments support the idea that the observed deficiency in signal-
ing reflects an intrinsic defect in the mutant Ig receptor.were derived from different sources and are thought to
bind to different epitopes on the Ig1 molecule. One of
the antibodies, 9A8, is known to bind to the V region of High Orders of Crosslinking Rather Than the
Concentration of Stimulants Can Overcome the (Bogen, 1989). Therefore, although possible, it is highly
unlikely that the single valine mutation in the  constant Signaling Deficiency of the Mutant Ig Receptor
Intracellular calcium responses in both wild-type (G) anddomain could affect the binding affinities or kinetic bind-
ing rates for all three antibodies. We chose R11-153 and mutant (V) 1-expressing cells were always proportional
to the concentration of stimulating antibodies. However,determined its relative binding affinity for gly-1 and val-
1. Serial dilutions of FITC-labeled R11-153 were used defective responses through val-1 were not overcome
with higher concentrations of antibodies (data notto stain two cell clones, G33 and V1, independently. The
titrations of the staining curves virtually overlap each shown). We next examined if higher orders of receptor
B Cell Development
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Figure 5. Intracellular Calcium Mobilization
following Stimulation with Monoclonal anti-
Antibodies
(A–C) Cells were loaded with the Ca2-sensi-
tive fluorescent dyes, Fluo-3 and Fura Red.
The cytoplasmic calcium concentrations are
shown as the ratio of Fluo-3 to Fura Red fluo-
rescence. To determine the basal levels of
the calcium concentrations, resting cells were
assayed for 30 s. Cells were then stimulated
with the monoclonal anti- antibodies (arrows).
The cell clones used in each assay are indi-
cated to the right of the calcium curves. G33
and G20 are independent clones expressing
wild-type (glycine) Ig receptors. V1 and V7
are independent clones expressing mutant
(valine) Ig1 receptors. The stimulant is indi-
cated in each panel: (A), 1 
g/ml R11-153;
(B), 1.2 
g/ml 9A8; and (C), 1 
g/ml L22.18.2.
(D) The Ig1 expression levels of the indicated
individual clones were determined by staining
with an FITC-labeled polyclonal anti- anti-
body and FACS analysis.
(E and F) Two staining assays were used to
compare the binding affinities of the valine-
and glycine-1 receptors with mAb R11-153.
FACS analysis of the staining of cell clones
G33 and V1 with the FITC-labeled R11-153.
Black lines stand for G33 cell staining, and
dotted lines stand for V1 cell staining. (E) A
series of the indicated concentrations of
FITC-R11-153 was used to stain the two dif-
ferent cell clones. The mean intensities of the
staining were determined by flow cytometry.
(F) FITC-R11-153 at the concentration of 100
ng/100 
l was incubated with serial dilutions
of purified 1 before the addition of cell sam-
ples in a binding competition assay (Goroff et
al., 1991). The mean intensities of the staining
after competition were determined by flow
cytometry.
(G) Super-crosslinking overcomes the differ-
ence in calcium responses in valine- versus
glycine-1 receptor carrying B cell clones.
G33 and V1 cells were treated with either 1 
g/ml biotinylated R11-153 alone or 1 
g/ml biotinylated R11-153 together with 20 
g/ml avidin.
The data were collected and analyzed as before.
(H) The calcium responses upon stimulation with NP13-BSA antigen. G33 and V1 cell clones were used. Cells were stimulated with
NP13-BSA antigen at 30 ng/ml, and data were collected and analyzed as before.
aggregation could correct the signaling defect observed not shown). Thus, high aggregation of surface Ig recep-
tors by this multivalent antigen can overcome the valinein val-1-expressing cells. Wild-type and mutant recep-
tor expressing cells were incubated with a biotinylated Ig receptor signaling defect. We also tried NP2.5-BSA,
which should mimic the bivalent stimulation of mono-anti-1 antibody and avidin and then assayed for intra-
cellular calcium responses by flow cytometry. As dem- clonal antibodies. Unfortunately, it did not give any cal-
cium response in either cell type (data not shown).onstrated in Figure 5G, further aggregation of surface
Ig receptors induces similar calcium responses in cells
expressing either 1 chain. Discussion
A similar phenotype was also observed when the multi-
valent antigen to which this 
1 BCR binds, NP13-BSA, Unlike most inbred strains, several mouse strains, in-
cluding SJL, BSVS, and FVB, have been found to havewas applied. The Ig
 carries the productively rearranged
VHDJH complex of the hybridoma B1-8 (Reth et al., 1987). a greatly reduced 1 expression (Geckeler et al., 1978;
Sun and Storb, 2001). These strains are close to eachWhen incorporated with the Ig1 light chain, the Ig re-
ceptor recognizes the hapten, NP. When NP13-BSA was other in the mouse genealogy tree (Beck et al., 2000),
suggesting that a common defect arose before the deri-used to stimulate the wild-type and valine cell clones,
similar calcium responses were induced in both clones vation of the current strains. Previous sequencing of the
functional elements of the 1 locus in SJL revealed a(Figure 5H). These responses were always proportional
to the concentrations of NP13-BSA administered, but candidate point mutation in the constant region that
might be responsible for the defect (Arp et al., 1982).similar responses were always found between these two
clones independent of the amount NP13-BSA used (data Southern blotting revealed that the same point mutation
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Figure 6. Position and Orientation of Valine 154 in a Fab Fragment
The model (designed by F. Stevens, Argonne National Laboratory) is based on the crystal structure of a representative wild-type (gly-containing)
murine  light chain (PDB code: 1INE) (Love et al., 1993).
also occurred in BSVS and FVB strains (Arp et al., 1982; valine Ig receptor is impaired, suggesting a mechanism
to account for underrepresentation of 1 B cells in thedata not shown). Furthermore, among the random bred
mice from Charles River laboratory, a complete correla- V-n mice.
We demonstrate, through the naturally occurring va-tion was found between the low 1 Ig production and
this point mutation (Ju et al., 1986). Here, we prove line mutation in C1, that light chains are involved in at
least two distinct stages of B development, independentthat the point mutation at position 154 in the C1 exon,
changing a glycine codon into a valine codon, is respon- of their role in receptor assembly: (1) development of
immature and transitional B cells and (2) generation and/sible for the 1 defect in SJL mice.
What is the molecular mechanism for the valine Ig or maintenance of peripheral mature B cells (Figures 3
and 4). Compared to the wild-type mice, the number ofdefect? The valine 1 Ig reaches a similar expression
level as the wild-type on the individual surviving B cells immature 1 B cells in bone marrow is reduced about
2- to 3-fold in V-n/V-n mice (Figures 4A and 4B), despitein mice and on the transfected cell clones (Figures 3, 4,
and 5D). In addition, using pulse-chase labeling, the the fact that the PGK-neo insertion dramatically in-
creases the 1 VJ rearrangement earlier (Figure 2). Inhybridoma producing SJL1 was found to have a normal
Ig secretion rate (Weiss et al., 1985). These findings spleen, the 1 transitional type 1 (T1) cell population in
V-n/V-n is also decreased around 3-fold (Figure 4D).suggest that the valine is not likely to cause a protein
processing problem. The stability of valine 1 Ig was Since the pre/pre-B cell development in V-n/V-n mice
is normal (Figures 3C and 3D), and considering thatalso found to be normal: the half-life of the valine 1 Ig
has been determined in vivo and found not to be different T1 B cells are more recent immigrants from the bone
marrow, the data suggest that the developmental stepsfrom that of the wild-type (Epstein, 1984). By using idio-
type markers, the SJL 1 chain is found to be able to from pre-B cells to the immature and T1 1 cells are
defective in V-n/V-n mice but that the migration fromassociate with the heavy chain in a similar fashion as
the wild-type 1, to the extent that these anti-idiotype the bone marrow to the periphery is normal. In spleen,
T1 B cells develop into T2 and mature B cells (Loder etantibodies are the result of heavy and light chain associ-
ation (Geckeler et al., 1978; Weiss et al., 1985). Further- al., 1999). In V-n/V-n mice, these steps also appear to be
defective for 1 cells. The numbers of T2 and mature 1more, the valine mutation occurs at position 154 in the
1 constant region, opposite to the IgH and IgL interac- B cells in these mice decrease further, 10- and 6-fold,
respectively (Figure 4C), while T1 cells only decreasetion face (Figure 6). These findings support the notion
that the valine mutation is unlikely to inhibit IgH and 3-fold. While T2 cells seem to be an intermediate popula-
tion between T1 and mature cells based on their IgMIg1 interactions. To further investigate the valine 1
defect, we proceeded to analyze the signaling capacity and IgD surface expression, it is still possible that some
mature B cells may develop directly from the T1 cellof the valine BCR. We found that signaling through the
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population (Loder et al., 1999). This might explain why extracellular domains of the receptor. In vivo, the signal
the defect in mature 1 B cells is less severe than in the intensity might be similar in extent to the one caused
T2 cells. by the bivalent crosslinking with monoclonal antibodies,
Signals through the BCR and its precursor complex since a strong signal, such as the one caused by the
are required for B cell development, peripheral mainte- supercrosslinking in vitro, is able to overcome the valine
nance, and activation. Studies have shown that BCR signaling defect. Glycine is conserved in C in most
signaling is functioning not only in early development species, while serine is found in some human and chim-
stages in the bone marrow (Kitamura et al., 1991) but panzee  chains. We now know that both serine and
in later stages as well, including B cell migration and glycine do not affect B cell development, while valine
development in spleen: the elimination of either the cyto- does (Sun and Storb 2001; this study). In contrast to
plasmic tail of Ig or the tyrosine kinase Syk causes a glycine and serine, substitution with valine introduces
severe developmental defect in early B cell develop- a hydrophobic patch (Figure 6) that could affect receptor
ment, leading to a reduction of the immature B cell aggregation (Finch et al., 1973) or association with other
population (Torres et al., 1996; Turner et al., 1995). Strik- surface molecules (such as CD22 or CD19). The intro-
ingly, no mature B cells were detectable with these mu- duction of a hydrophobic patch could disrupt receptor
tations, suggesting that these BCR signaling alterations function directly by altering an interaction domain or
strongly inhibit the development into mature B cells indirectly by changing the conformation of the assem-
(Loder et al., 1999; Turner et al., 1995). While T1 cells bled receptor. The position of the valine mutation may
are still in the outer periarteriolar lymphoid sheet (PALS), suggest that this face of 1 interacts with constituents
close to the primary follicle, T2 and mature B cells are of the BCR such as Ig/Ig or some unknown BCR
located in the follicle (Loder et al., 1999). The BCR signal- ligand. The further unraveling of the molecular and cellu-
ing at the T1 to T2/mature stage transitions may play a lar basis of the valine defect will deepen our understand-
crucial direct role in leading T1 B cells to develop into ing of BCR-mediated signaling in the development,
the primary follicle. As our data demonstrate, Ig light maintenance, and activation of B cells.
chain, once expressed on the cell surface, affects the
BCR signaling at this stage, as well as the early develop-
Experimental Procedures
mental stage from pre-B to immature B cells.
There is little known about the development of mar- Generation of Mutant (V-n) Mice
ginal zone B cells. It was suggested that MZ B cells The strategy for generating the targeting vector for S-n mice (Sun
and Storb, 2001) was used to make the V-n targeting construct. Pointare derived from the mature (naive follicular) B cells
mutations were introduced into the C1 constant region, changing a(Dammers et al., 1999). Furthermore, T2 cells have also
glycine codon (GGT) at position 154 of the 1 chain to a valinebeen suggested to contain the precursors of MZ cells
codon (GTT). This mutation disrupts a Kpn1 (Asp718) restriction
(Cariappa et al., 2001; Loder et al., 1999). Ultimately, the site. The linearized targeting vector was electroporated into AB2.2
MZ B cells develop from the immature B cells that have embryonic stem (ES) cells (purchased from Lexicon company, The
migrated into the spleen. In V-n/V-n mice, the extent of Woodlands, TX), and G418- and gancyclovir-resistant clones were
selected and further screened by Southern blotting. The screeningthe deficiency (3-fold) in MZ 1 cells is the same as
method for V-n mice was the same as for S-n mice (Sun and Storb,that in immature/transitional cells, suggesting that the
2001). Positive clones were injected into C57BL/6 blastocysts todevelopmental defect for 1 MZ B cells, if any, is less
make chimeric mice.severe than for T2 and mature cells. Generation of MZ
Germline transmitting mice were generated by mating of chimeras
B cells in spleen has been suggested to require a much with C57BL/6 mice. To generate a / background, the mice were
weaker BCR signal than the generation of follicular ma- bred with  knockout mice (Chen et al., 1993; Kim et al., 1994). The
ture cells: the reduced BCR signals in CD45- and Btk- mouse designations are G and V-n, for wild-type (Glycine) and valine
targeted (Valine-neo), respectively.deficient mice apparently are able to direct proper devel-
opment of MZ B cells but not of mature follicular B cells
in spleen (Cariappa et al., 2001; Loder et al., 1999; Ma- Southern Blot Analysis
kowska et al., 1999). Most likely in V-n mice, due to the DNA isolation from mouse tissues was performed as described (Kim
et al., 1994). The genotype of the  loci was revealed by hybridizingdefective signal transduction capacity of valine 1 Ig
with an EcoRI-XbaI fragment from pRI/XbaI (Chen et al., 1993). Toreceptors (Figure 5A–5C), only a less intense signal may
determine the genotypes and rearrangement levels of the 1 locus,be able to be transduced, which is relatively permissive
a 1.2 kb XbaI-KpnI fragment (J1XbaI-C1KpnI) in the J1 to C1for the development of MZ 1 cells but much less for
region and a 0.4 kb EcoRI-HindIII fragment (3C1), 4 kb downstream
the development of mature 1 cells. of the C1 exon (Storb et al., 1989), were used as probes.
Although several components of the receptor and sig-
naling cascades required for B cell development have
PCR and Sequence Analysis
been defined, the mechanisms by which the BCR initi- The positions of PCR primers in the  locus are indicated in Figure
ates these signals are unknown. Peripheral activation 2A. To distinguish the rearrangements in splenic cells in various
in vivo requires aggregation of the receptor, yet no se- mice, PCR with the primers 5Nreg and 3J3C1 were used. The
lecting ligand has been identified in the bone marrow. cycling conditions for the reactions were optimized to assure linear
amplification. PCR conditions were as follows: 94C for 5 min, thenSurface assembly of the BCR is required to transduce
94C for 30 s, 65C for 30 s, 72C for 2 min, with 25 cycles. For /,survival signals (Lam et al., 1997). Assembled receptors
heterozygous G/V-n, and G/S-n samples (Table 1), the PCR productsmay self-aggregate on the surface to initiate a ligand-
were digested by Asp718 before cloning, and the bands from the
independent signal (Reth et al., 2000; Schamel and Reth, targeted allele were cloned. The PCR products were cloned into the
2000). The specific structural domains required for the pCR-BluntII-TOPO vector and sequenced according to the manu-
self-aggregation of BCR complexes are unknown, al- facturer’s instructions (Invitrogen, Carlsbad, CA).The sequences of
the primers used for these assays are: 5Nreg: 5-CGCGAATTCTthough the aggregation is likely to include one or more
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CAGGCTCCCTGATTGGAGACAAGG-3; 3J3C1: 5-GACCTAGGAA 153 (Clone #, Pharmingen), 9A8 (Clone #, Sigma, St. Louis, MO),
L22.18.2 (Kim et al., 1994); NP13-BSA and NP2.5-BSA (Solid PhaseCAGTCAGCACGGG-3.
Sciences, San Rafael, CA); and Avidin (Sigma).
Flow Cytometry
Antibody Titration and Competition AssayBone marrow (femur and tibia from both legs) and spleen tissues
In order to determine the avidities of R11-153 to the two kinds ofwere disaggregated using a nylon cell strainer (Becton-Dickinson).
Ig1 receptors, two types of immunofluorescence staining wereRed blood cells were then lysed by hypotonic shock. The cell debris
used (Goroff et al., 1991). First, a series of FITC-R11-153 antibodywas removed by a nylon strainer. Anti-CD16/CD32 monoclonal anti-
dilutions (1 ng to 10 
g/100 
l/0.5 	 106 cells) was used to stainbody (Clone 2.4G2) was first used to block the Fc receptors. Cells
the two cell clones independently. The titrated staining curves forwere then stained (106 cells/100 
l) in the staining buffer (DMEM,
these two clones were determined by the mean fluorescence intensi-free of serum, with 0.1% BSA) with the respective antibodies. Fluo-
ties versus the concentration of the antibodies added. The concen-rescence analysis was performed on a FACScan (Becton-Dickinson)
tration of the antibody required to bind 50% of both cell types (MFI50)and analyzed by CELLQuest software. The cells were gated for
was determined. Second, a series of concentrations of pure 1lymphocytes by forward and side scatter, and a total of 10,000 were
protein (IgG1/1, Pharmingen) was used to compete out the anti-collected unless described otherwise. 1 B cells were revealed by
body staining. FITC-R11-153, at the concentration of 100 ng/100 
l,biotinylated L22.18.2 monoclonal antibody (Kim et al., 1994; Weiss
was incubated with 1 ng to 1 
g pure 1 protein on ice for 1 hr,et al., 1983) with PE-, Cychrome- or PerCP-labeled streptavidin as
followed by incubation with 0.5 	 106 cells to stain the cells. Thethe secondary reagent. 2 and 3 B cells were revealed by FITC-
competition curves for the two cell clones were determined by thelabeled anti-2/3 antibody (2B6) (Bogen, 1989; Engel et al., 1999).
staining intensities versus the concentration of competitive pure 1FITC-labeled anti-CD21 (7G6), PE-labeled anti-CD43 (S7), Cy-
antibody.chrome-labeled anti-B220 (RA3-6B2), FITC-labeled anti-IgM (poly-
clonal, Southern Biotech Ass., AL), Cy5-labeled anti-IgM (Jackson
AcknowledgmentsImmunoResearch Lab, PA), and PE-labeled anti-IgD (11-26, South-
ern Biotech Ass., AL) were used as indicated. To measure the Ig1
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